FDA — authorised 31 October 1986
- Status: approved
🇺🇸 Noroxin in United States
FDA authorised Noroxin on 31 October 1986
Marketing authorisations
FDA — authorised 31 October 1986
- Application: NDA019384
- Marketing authorisation holder: MERCK
- Local brand name: NOROXIN
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 17 June 1991
- Application: NDA019757
- Marketing authorisation holder: MERCK
- Local brand name: CHIBROXIN
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
Noroxin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Noroxin approved in United States?
Yes. FDA authorised it on 31 October 1986; FDA authorised it on 31 October 1986; FDA authorised it on 17 June 1991.
Who is the marketing authorisation holder for Noroxin in United States?
Marketing authorisation holder not available in our data.